In this prospective cohort study of persons with HIV (CD4 counts>350 cells/mm3) and pulmonary TB we measured a significant decline in CD8 T cell immune activation that persisted for at least 6 months after completion of TB therapy. The gene discussed is CD8A; the disease is pulmonary tuberculosis.